Shanghai Pharmaceuticals Holding Co., Ltd. (SH PHARMA) has announced that its Board of Directors will convene on Thursday, 27 August 2026. The meeting’s agenda includes:

• Approval of the consolidated interim results for the six months ended 30 June 2026. • Consideration of an interim dividend payment for the period.

The notice was signed by Chairman Yang Qiuhua on 17 August 2026 in Shanghai. Current board composition comprises four executive directors—Yang Qiuhua, Shen Bo, Li Yongzhong and Dong Ming—one non-executive director, one employee-representative director, and four independent non-executive directors.